Page 30 - CIRN Annual Report 2017

Immunization Research Network. Preparedness for and response to meningococcal
Abstracts of Canadian Immunization Conference 2016; 2016 Dec 6–8; Ottawa, ON.
program in a university setting: A Canadian Immunization Research Network study.
McNeil, J Mutch, D MacKinnon Cameron, K Marty, D Scheifele, and the Canadian
schedules of 4CMenB vaccination in adolescents and young adults [abstract]. In:
Research Network (CIRN) study [abstract]. In: Program and abstracts of the 19th
Knowledge, attitudes, beliefs, and behaviors of college students and staff during
Rapid surveillance for health events following a mass meningococcal B vaccine
collaborative, team-oriented framework for delivering research impact. To date, CIRN teams published 15 articles,
McNeil , D MacKinnon-Cameron, K Marty, G De Serres, E Dubé, JA Bettinger.
CIRN uses an integrated approach to disseminating knowledge as well as training. The network provides a highly
a meningococcal B outbreak vaccination program: A Canadian Immunization
JM Langley, DM MacDougall, BA Halperin, A Swain, SA Halperin, KA Top, SA
J Langley, S Gantt, C Quach, J Alcantara, J Bettinger, S Halperin, B Ward, S
outbreaks: Preliminary safety results of a randomized controlled trial of two
presented over 45 abstracts at 14 conferences, and delivered 8 reports to stakeholders, including public health.
Annual Conference on Vaccine Research; 2016 Apr 18–20; Baltimore, MD.

List of Publications, Abstracts and Presentations
Vaccine. 2016;34:4046–4049. DM MacDougall, JM Langley, L Li, D MacKinnon-Cameron, K Top, SA McNeil, BA Halperin, A Swain, JA Bettinger, SA Halperin; Canadian Immunization Research Network. Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program. Vaccine. 2017;35:2520–2530. doi: 10.1016/j.vaccine.2017.02.011. PubMed PMID: 283

CLINICAL TRIALS NETWORK M Pinto, D Scheifele. Discussion the need for an adolescent hepatitis B vaccine booster in infant vacinees. Paediatrics & Child Health 2014, 19(8): 404. SA Halperin et al. A Phase 1 randomized, single-center, double-blind, placebo controlled, dose-ranging study to evaluate the safety and immunogenicity of the BPSC-1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in healthy adult subjects. CIHR Science Council, January 21, 2015.